Home > Insider Trading > Filing (0001610717-25-000240)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628171	Revolution Medicines Inc.	RVMD	Biological Products, (No Disgnostic Substances) (2836)	472029180

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1969082	Jeff Cislini	C/O Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	General Counsel	No	No	No	No

Transaction Summary

Sold:	1,878 shares	Avg. Price: $39.83	Total Value: $74,800.74
Number of Shares After Transactions:	56,005 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-06-16	1,878	$39.83	56,005	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
This transaction was executed in multiple trades in prices ranging from $39.5915 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 160 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025.
Includes 49,054 RSUs.